OMIC Digest Archives 2019

OMIC Digest: Vol. 29 | No. 1 | 2019

Feature: Dangers posed by systemic medications
Eye on OMIC: Dividend and rate news for 2020 and an industry outlook
Policy Issues: Limits of liability
Closed Claim Study: Other factors delay the diagnosis of Plaquenil toxicity
Risk Management Remedies: Tips to avoid medication errors and litigation
< click to view or download

OMIC Digest: Vol. 29 | No. 2 | 2019

Feature: Equipment and device issues in claims.
Eye on OMIC: Private equity partnerships, streamlined underwriting, and cyber enhancements
Policy Issues: Coverage when machines malfunction
Closed Claim Study: Equipment malfunction or improper set up of a surgical device?
Risk Reduction Strategies: Ensure safe use of equipment
< click to view or download

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.